Cargando…

Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?

Amyotrophic lateral sclerosis (ALS) is a devastating neurodegenerative disorder that still lacks an efficient therapy. The barriers between the central nervous system (CNS) and the blood represent a major limiting factor to the development of drugs for CNS diseases, including ALS. Alterations of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alarcan, Hugo, Al Ojaimi, Yara, Lanznaster, Debora, Escoffre, Jean-Michel, Corcia, Philippe, Vourc’h, Patrick, Andres, Christian R., Veyrat-Durebex, Charlotte, Blasco, Hélène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319288/ https://www.ncbi.nlm.nih.gov/pubmed/35887567 http://dx.doi.org/10.3390/jpm12071071

Ejemplares similares

Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020)

Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients
por: Alarcan, Hugo, et al.
Publicado: (2023)

The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration
por: Haouari, Shanez, et al.
Publicado: (2022)

Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis
por: Alarcan, Hugo, et al.
Publicado: (2021)

Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1
por: Haouari, Shanez, et al.
Publicado: (2023)

Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells
por: Hergesheimer, Rudolf, et al.
Publicado: (2020)

Therapeutic antibodies – natural and pathological barriers and strategies to overcome them
por: Al Ojaimi, Yara, et al.
Publicado: (2022)

The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
por: Hergesheimer, Rudolf C, et al.
Publicado: (2019)

Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020)

Lipidomics Reveals Cerebrospinal-Fluid Signatures of ALS
por: Blasco, H., et al.
Publicado: (2017)

TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2019)

Iron Metabolism Disturbance in a French Cohort of ALS Patients
por: Veyrat-Durebex, Charlotte, et al.
Publicado: (2014)

How Can a Ketogenic Diet Improve Motor Function?
por: Veyrat-Durebex, Charlotte, et al.
Publicado: (2018)

Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis
por: Lanznaster, Débora, et al.
Publicado: (2020)

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS
por: Lanznaster, Débora, et al.
Publicado: (2018)

The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls
por: Petillon, Camille, et al.
Publicado: (2019)

Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2022)

Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation
por: Dangoumau, Audrey, et al.
Publicado: (2021)

NSC-34 Motor Neuron-Like Cells Are Unsuitable as Experimental Model for Glutamate-Mediated Excitotoxicity
por: Madji Hounoum, Blandine, et al.
Publicado: (2016)

Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases
por: Lanznaster, Débora, et al.
Publicado: (2022)

(1)H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
por: Blasco, Hélène, et al.
Publicado: (2010)

Correction: (1)H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
por: Blasco, Hélène, et al.
Publicado: (2010)

Taking advantage of saliva
por: Van Epps, Heather L.
Publicado: (2006)

Bites and Some Methods of Taking Them
por: Mahoney, J.
Publicado: (1898)

How to Take Advantage of Mentorship
por: Singla, Manish B.
Publicado: (2015)

Does the Coronavirus Epidemic Take Advantage of Human Optimism Bias?
por: Bottemanne, Hugo, et al.
Publicado: (2020)

Plant peptides – taking them to the next level
por: De Coninck, Barbara, et al.
Publicado: (2016)

Probiotics: Should All Patients Take Them?
por: Katkowska, Marta, et al.
Publicado: (2021)

Taking advantage of international investment opportunities
por: Lydon, Tom
Publicado: (2010)

Editorial: Taking advantage of the JACMP website
Publicado: (2008)

Bdellatomy. Taking Advantage of a Leech
Publicado: (1868)

Medical Students Will Take Care of the People, We Need to Take Care of Them
por: Alahdab, Fares
Publicado: (2022)

Brown adipose tissue activity as a target for the treatment of obesity/insulin resistance
por: Poher, Anne-Laure, et al.
Publicado: (2015)

Open Access: Taking Full Advantage of the Content
por: Bourne, Philip E., et al.
Publicado: (2008)

Taking advantage of between- and within-participant variability?
por: Perret, Cyril, et al.
Publicado: (2014)

Taking advantage of unexpected WebCONSORT results
por: Cobo, Erik, et al.
Publicado: (2016)

Taking Advantage of the Morpheein Behavior of Peroxiredoxin in Bionanotechnology
por: Ardini, Matteo, et al.
Publicado: (2021)

Swindlers: How Sharpers Take Advantage of the Unwary
Publicado: (1869)

Taking advantage of noise in quantum reservoir computing
por: Domingo, L., et al.
Publicado: (2023)

Trauma-Induced Damage-Associated Molecular Patterns-Mediated Remote Organ Injury and Immunosuppression in the Acutely Ill Patient
por: Vourc’h, Mickael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bmbflcsmojt0kqhkejracv1akv